logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Endometrial cancer: add-on trastuzumab extends survival in rare type

Phase 2 trial of women with recurrent/advanced HER2/neu-positive uterine serous carcinoma.